Antiviral therapy may prevent liver cancer in patients with hepatitis B

the ONA take:

The results of a first-of-its-kind analysis of more than 2,600 adult participants with hepatitis B revealed the anticancer properties of antiviral therapy for hepatitis B. The antiviral therapy prevents hepatitis B from developing into hepatocellular carcinoma (HCC), the most common form of liver cancer. HCC typically occurs in persons 50 years or older and is more common in men. During a 5-year follow-up period, researchers found that those patients treated with antiviral therapy had significantly lower occurrence of HCC.

Antiviral therapy may prevent liver cancer in patients with hepatitis B
Antiviral therapy may prevent liver cancer in patients with hepatitis B
DETROIT – Researchers have found that antiviral therapy may be successful in preventing hepatitis B virus from developing into the most common form of liver cancer, hepatocellular carcinoma (HCC).
READ FULL ARTICLE From Science Codex
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs